Scot Harper
Technik-/Wissenschafts-/F&E-Leiter bei RADIOPHARM THERANOSTICS LIMITED
Ursprung des Netzwerks ersten Grades von Scot Harper
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 14 | |
| Subsidiary | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Scot Harper
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Founder Corporate Secretary | |
| IMUGENE LIMITED | Biotechnology | Founder Corporate Secretary | |
| AROVELLA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
NanoMab Technology Ltd.
 NanoMab Technology Ltd. Pharmaceuticals: MajorHealth Technology NanoMab Technology Ltd. is a Chinese biopharmaceutical company that focuses on developing radiopharmaceuticals for cancer precision therapies. NanoMab Technology is based in Shanghai, CN and was founded in 2016 by Hong-Hoi Ting and Henry Ho. The private company aims to address the unmet medical needs of cancer patients worldwide by developing a pipeline of theranostics using its proprietary camelid antibody platform. NanoMab has filed an IMPD on NM-01 with the UK Medical Healthcare Products Regulatory Agency and is developing its radio-labelled NM-02 for clinical trials in both imaging and treatment of breast and gastric cancers. The company's third program, NM-03, is a single domain antibody targeting a pan-cancer marker and is in preclinical development as a theranostic. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses. | Pharmaceuticals: Major | President Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman | |
| IPSEN | Pharmaceuticals: Major | Chief Executive Officer | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chairman | |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| UNIQURE N.V. | Biotechnology | Chairman | |
| The College of William & Mary | College/University | Undergraduate Degree | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Camping & Education Foundation | Director/Board Member | ||
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Bocconi | College/University | Masters Business Admin | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| FLUOROPHARMA MEDICAL, INC. | Miscellaneous Commercial Services | Chief Executive Officer | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| ERASCA, INC. | Pharmaceuticals: Major | General Counsel | |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Medical Specialties | President | |
| University of Vermont | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
Medical Imaging & Technology Alliance
 Medical Imaging & Technology Alliance Miscellaneous Commercial ServicesCommercial Services Medical Imaging & Technology Alliance operates as an organization and a collective voice of medical imaging equipment, radiopharmaceutical manufacturers, innovators, and product developers. The company is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Academy of Molecular Imaging
 Academy of Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Academy of Molecular Imaging operates as a non-profit organization. The company is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Bracco Imaging SpA
 Bracco Imaging SpA Medical SpecialtiesHealth Technology Bracco Imaging SpA manufactures and develops diagnostic imaging solutions for public and private hospitals, imaging centers and private practices. The firm's services include radiology, X-ray imaging, magnetic resonance imaging and ultrasound applications. The company was founded in 1985 and is headquartered in Milan, Italy. | Medical Specialties | Sales & Marketing | |
| The Council on Radionuclides & Radiopharmaceuticals, Inc. | Director/Board Member | ||
| Medical Imaging Technology Associates | Director/Board Member | ||
| ACCURAY INCORPORATED | Medical Specialties | Corporate Officer/Principal | |
National Italian American Foundation, Inc.
 National Italian American Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous National Italian American Foundation (NIAF) provides education and careers to Italian Americans. It provides services through the development of educational programs, advocacy of representation in government, monitoring how Italians and Italian-Americans are depicted in the media and the forging of ties between the United States and Italy. the firm also offers scholarships for Italian-American students and for students emarking on Italian-based studies. NIAF was founded in 1975 and is headquartered at Washington, DC. | Investment Trusts/Mutual Funds | Director/Board Member | |
Bracco Diagnostics, Inc.
 Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Turin | College/University | Undergraduate Degree | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| Brody School of Medicine | College/University | Doctorate Degree | |
| University of Glasgow | College/University | Doctorate Degree | |
NewYork-Presbyterian Hospital
 NewYork-Presbyterian Hospital Hospital/Nursing ManagementHealth Services NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PETNET Solutions, Inc.
 PETNET Solutions, Inc. Drugstore ChainsRetail Trade PETNET Solutions, Inc. produces and distributes pet radiopharmaceuticals products. The company was founded on September 27, 2000 and is headquartered in Knoxville, TX. | Drugstore Chains | Chief Executive Officer | |
| Ansto Radiopharmaceuticals | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 33 |
| Australien | 5 |
| Italien | 5 |
| Frankreich | 3 |
| Kanada | 3 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Health Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 71 |
| Corporate Officer/Principal | 43 |
| Chairman | 20 |
| President | 18 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Hopper | 33 |
| Colin Goddard | 26 |
| David Meek | 19 |
| Douglas Bailey | 12 |
| Leila Alland | 11 |
| Thomas Tulip | 10 |
| Vittorio Puppo | 8 |
| Katherine K. Parker | 8 |
| Binh Nguyen | 8 |
| Chandra D. Lovejoy | 7 |
| Alison Armour | 7 |
| Michael Baker | 7 |
| Hong Ma | 7 |
| P. David Mozley | 6 |
| Ian Turner | 6 |
- Börse
- Insiders
- Scot Harper
- Unternehmensverbindungen
